What is Ramucirumab?
Category: Prescription Drugs
Most popular types: Cyramza
Ramucirumab is an injectable anti-cancer agent that is used to treat advanced gastric cancer, gastro-esophageal junction adenocarcinoma, and certain types of non-small cell lung cancer.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Adenocarcinoma (non-small cell lung cancer) | 5 | 0 | |
| Lung cancer | 2 | 0 | |
| Squamous cell carcinoma (non-small cell lung cancer) | 2 | 0 | |
| Non-small cell lung cancer | 1 | 0 | |
| Salivary gland-like carcinoma (non-small cell lung cancer) | 1 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 0 |
Commonly reported side effects and conditions associated with Ramucirumab
| Side effect | Patients | Percentage |
|---|---|---|
| Fluid retention (edema) | 1 |
What people switch to and from
Patients started taking Ramucirumab after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Chemotherapy | 1 |
Last updated: